Chemical activators of Vmn2r60 include a variety of compounds that enhance the protein's activity through a cascade of intracellular signaling events. Forskolin is known to directly stimulate adenylate cyclase, leading to an increase in cyclic AMP (cAMP) levels within the cell. This elevation in cAMP activates protein kinase A (PKA), which can then phosphorylate Vmn2r60, resulting in its activation. Similarly, Isoproterenol functions as a beta-adrenergic receptor agonist that also activates Gs proteins, which in turn stimulate adenylate cyclase. This stimulation boosts cAMP production, activating PKA that subsequently phosphorylates and activates Vmn2r60. Epinephrine, a natural hormone and neurotransmitter, binds to adrenergic receptors coupled to Gs proteins, which can induce the same adenylate cyclase-cAMP-PKA pathway, leading to the activation of Vmn2r60.
In addition, Histamine, which binds to H2 receptors, activates adenylate cyclase through Gs proteins, and Prostaglandin E2 (PGE2) through EP2/EP4 receptors, follows the same route of increasing cAMP and PKA activity, culminating in the activation of Vmn2r60. IBMX and Rolipram, both phosphodiesterase inhibitors, prevent cAMP breakdown, thus maintaining PKA activation and facilitating the phosphorylation and subsequent activation of Vmn2r60. Dopamine, by activating D1-like receptors, and Adenosine, via A2A receptors, both lead to increased adenylate cyclase activity and thus elevate cAMP levels, enabling PKA to phosphorylate and activate Vmn2r60. Glucagon, through its receptor, stimulates adenylate cyclase, raising cAMP and enhancing PKA activity, which is necessary for Vmn2r60 activation. Terbutaline, as a beta2-adrenergic receptor agonist, and Zaprinast, by inhibiting PDE5, both result in raised cAMP levels, resulting in PKA-mediated phosphorylation and activation of Vmn2r60. Each of these chemicals, through their unique interactions with cellular signaling pathways, ensure the functional activation of Vmn2r60 by converging on the same fundamental molecular mechanism: the elevation of cAMP and activation of PKA, which then directly activates Vmn2r60.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Agonist for beta-adrenergic receptors which are linked to Gs proteins that stimulate adenylate cyclase, leading to Vmn2r60 activation. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Binds to adrenergic receptors, stimulates adenylate cyclase via Gs proteins, increasing cAMP which activates PKA to phosphorylate Vmn2r60. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Binds to H2 receptors that stimulate adenylate cyclase through Gs proteins, increasing cAMP and PKA activity, which can activate Vmn2r60. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Binds to EP2/EP4 receptors, activating adenylate cyclase via Gs proteins to increase cAMP and PKA activity, leading to Vmn2r60 activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterase leading to increased cAMP levels, sustained PKA activation, and subsequent activation of Vmn2r60. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase inhibitor, increases cAMP concentrations, leading to PKA-mediated phosphorylation and activation of Vmn2r60. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Activates D1-like receptors that stimulate adenylate cyclase and cAMP production, leading to PKA activation and Vmn2r60 phosphorylation. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Through A2A receptors, activates adenylate cyclase, raises cAMP, which in turn activates PKA that phosphorylates and activates Vmn2r60. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Agonist at beta2-adrenergic receptors, increases adenylate cyclase activity, cAMP levels, and thus activates PKA and Vmn2r60. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Inhibits phosphodiesterase, particularly PDE5, leading to increased cAMP, enhanced PKA activation, and phosphorylation of Vmn2r60. | ||||||